CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,321 shares at $20.88 ($69,342)
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 20,141 shares at an average $29.16 ($587,242)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale EVP, Head of Research & Dev sold 16,558 shares at an average $26.13 ($432,663)
- 4 Planned sale PRINCIPAL ACCOUNTING OFFICER sold 11,421 shares at $26.08 ($297,912)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Grant or award Director acquired 37,244 shares (grant or award)
- 4 Option exercise Director acquired 8,107 shares (option exercise)
- 4 Option exercise Director acquired 8,107 shares (option exercise)
- 4 Option exercise Director acquired 8,107 shares (option exercise)
Page 1 of 70 · 1,382 filings